drugset / Trial / NCT06243120

Intravenous Lidocaine for Treating Intrathecal Fentanyl Induced Pruritus

NCT06243120

Phase 0 Unknown 54 enrolled Ain Shams University
RandomizedParallel-groupSingle-blindTreatment

Summary

The study will assess efficacy of intravenous lidocaine 1 mg/kg diluted with 0.9% sodium chloride to a volume of 100 ml to suppress intrathecal fentanyl induced pruritus. This will be compared to control group who will receive 100 ml normal saline as placebo. The main outcome is regression of initial VAS score with incidence of pruritus.

Timeline

Start
2024-03-01
Primary completion
2024-09-01
Completion
2024-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 1 mg/kg Intravenous

Indications

No indication recorded.